Knee Replacement clinical trials at UCSF
3 research studies open to eligible people
Knee replacement is surgery to replace a damaged knee joint. UCSF has trials for patients who experience knee pain after surgery. One study compares antibiotics given before surgery to see if it can prevent infection. Another trial looks at the best dose of a medication to reduce pain after surgery.
Antibiotic Prophylaxis in Patients Undergoing Elective TKA- Multi-center Trial
open to eligible people ages 18 years and up
The Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty (TKA): Multi-Center Trial is a study that will compare the effectiveness of various perioperative strategies for antibiotic delivery as prophylaxis for periprosthetic joint infections (PJI) and surgical site infection in elective primary TKA. The investigators hypothesize that a single dose of prophylactic antibiotic administered within 60 minutes before the incision is not an effective way to prevent PJI in elective primary total knee arthroplasty (TKA). The investigators also hypothesize that the prolonged delivery (24 hours) of antibiotic prophylaxis after surgery does not further reduce the incidence of PJI in elective primary TKA. Duke University is the only site recruiting both primary total knee arthroplasty and unilateral knee arthroplasty.
San Francisco, California and other locations
Dexamethasone in Total Knee Arthroplasty
open to eligible people ages 18 years and up
The purpose of this study is to determine the most efficacious and safest dexamethasone dose given intraoperatively during total knee arthroplasty that reduces postoperative opioid consumption and pain, improves postoperative nausea and vomiting, and minimizes postoperative complications.
San Francisco, California and other locations
The Use of Venlafaxine in Reducing Pain in Primary Total Knee Replacement
open to eligible people ages 18-75
Patients experience pain after their knee replacement surgery - and some may continue to experience persistent pain long after their knee replacement surgery. Traditional pain management strategies reply on pain medication such as opioids for pain control. However, these drugs do not work well for pain associated with movement or the the nerve pain (tingling, electrical sensations) after surgery. In addition, opioids are associated with significant side effects such as nausea, vomiting, respiratory depression, depression, cognitive dysfunction and risk of persistent opioid use. Neuropathic pain medications, such as venlafaxine are effective in managing nerve pain. Recent studies also support its potential role in acute pain management. Here, we propose a prospective randomized clinical trial 1) to evaluate the efficacy of Venlafaxine in reducing pain intensity and opioid consumption at post-operative day 1 (POD1) and 1- week after surgery, and 2) to examine whether the use of Venlafaxine will reduce the incidents of chronic postsurgical pain in TKA patients at 3-month time point.
San Francisco, California
Our lead scientists for Knee Replacement research studies include Thomas Vail Matthias Behrends, MD.
Last updated: